The Crossroads of Special Operations

Sunday, May 9, 2021

Army COVID-19 vaccine may produce a side benefit: Cure for the common cold | MCCLATCHY DC

Must Read

A COVID-19 vaccine is currently being developed by scientists from the Walter Reed Army Institute of Research. This also has advancing characteristics that may be able to prevent strains of the common cold in the future and to target different types of coronavirus. Walter Reed’s researchers have also found that there is very little mutation occurring in the virus. That means just one vaccine could work for the entire global population as confirmed by Dr. Morgane Rolland, chief of viral genetics for the Henry M. Jackson Foundation, which is supporting Walter Reed’s research.

Source: https://www.mcclatchydc.com/news/coronavirus/article245665350.html?utm_source=Sailthru&utm_medium=email&utm_campaign=EBB%2009.15.20&utm_term=Editorial%20-%20Early%20Bird%20Brief

- Advertisement -spot_img

- Advertisement -

Latest News

Industry supports Special Ops with lethality enhancements | National Defense

From small arms modifications and related sighting systems to mounts for crew-served weapons, the industry is giving the US...

- Advertisement -

More Articles Like This

- Advertisement -spot_img